D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
2019 · Frontiers in Psychiatry · 121 citations
https://doi.org/10.3389/fpsyt.2019.00025
G
Glen B. Baker
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
110
Citations
6
h-index
6
i10-index
Glen B. Baker is an academic researcher from University of Alberta. The author has contributed to research in topics: Neurotransmitter Receptor Influence on Behavior & Neuroscience and Neuropharmacology Research & Parkinson's Disease Mechanisms and Treatments. The author has an h-index of 6, co-authored 6 publications.
Papers by this author
worksDisease‐modifying effects of ganglioside GM1 in Huntington's disease models
2017 · EMBO Molecular Medicine · 75 citations
https://doi.org/10.15252/emmm.201707763
Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders?
2021 · Biomolecules · 72 citations
https://doi.org/10.3390/biom11071030
Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain
2017 · Retrovirology · 67 citations
https://doi.org/10.1186/s12977-017-0370-5
A dynamic role for dopamine receptors in the control of mammalian spinal networks
2020 · Scientific Reports · 60 citations
https://doi.org/10.1038/s41598-020-73230-w
The antidepressant phenelzine protects neurons and astrocytes against formaldehyde‐induced toxicity
2010 · Journal of Neurochemistry · 56 citations
https://doi.org/10.1111/j.1471-4159.2010.06857.x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat